The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing

Name: The future of carcinogenicity risk assessment: AI-powered, ethical alternatives to traditional testing
Start: 2025-04-02

Sponsored by Eurofins Discovery2025-04-02T14:00:00

Embryonic,Stem,Cells,,,Cellular,Therapy,,,3d,Rendering

Explore how a Weight of Evidence (WoE) approach uses in vitro methods and artificial intelligence (AI) to transform carcinogenicity risk assessment, reducing reliance on animal studies while enhancing compliance with FDA and ICH guidelines.